{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:58:00Z","timestamp":1785560280842,"version":"3.56.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2169\/internalmedicine.6575-25","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:08:11Z","timestamp":1765404491000},"page":"2149-2153","source":"Crossref","is-referenced-by-count":0,"title":["Polychondritis and Arthritis in a Patient with Coexisting Alkaptonuria and Psoriasis Vulgaris"],"prefix":"10.2169","volume":"65","author":[{"given":"Kensei","family":"Shono","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serina","family":"Koto","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Jubashi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Rheumatic Disease Center, Sasebo Chuo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Rheumatic Disease Center, Sasebo Chuo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wu K, Bauer E, Myung G, Fang MA. Musculoskeletal manifestations of alkaptonuria: a case report and literature review. Eur J Rheumatol 6: 98-101, 2019.","DOI":"10.5152\/eurjrheum.2018.18116"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yuce Inel T, Kisa PT, Balci A, et al. Inflammatory rheumatic diseases in patients with ochronotic arthropathy. Mod Rheumatol 31: 1031-1037, 2021.","DOI":"10.1080\/14397595.2020.1868121"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spreafico A, Millucci L, Ghezzi L, et al. Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) 52: 1667-1673, 2013.","DOI":"10.1093\/rheumatology\/ket185"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Braconi D, Giustarini D, Marzocchi B, et al. Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project. Osteoarthritis Cartilage 26: 1078-1086, 2018.","DOI":"10.1016\/j.joca.2018.05.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Albataineh E, Alsbou M, Al-Sarayreh S, Al-Tarawneh I, Alnawaiseh N. Levels of pro-inflammatory mediators CRP, IL-1\u03b2 and IL-6 in alkaptonuria patients. J Biol Life Sci 6: 1-10, 2014.","DOI":"10.5296\/jbls.v6i1.6445"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Millucci L, Braconi D, Bernardini G, et al. Amyloidosis in alkaptonuria. J Inherit Metab Dis 38: 797-805, 2015.","DOI":"10.1007\/s10545-015-9842-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McAdam LP, O&apos;Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55: 193-215, 1976.","DOI":"10.1097\/00005792-197605000-00001"},{"issue":"6 Pt 1","key":"8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","volume":"89","author":"JM Damiani","year":"1979","unstructured":"8. Damiani JM, Levine HL. Relapsing polychondritis - report of ten cases. Laryngoscope 89 (6 Pt 1): 929-946, 1979.","journal-title":"The Laryngoscope","ISSN":"https:\/\/id.crossref.org\/issn\/0023-852X","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Michet CJ Jr, McKenna CH, Luthra HS, O&apos;Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104: 74-78, 1986.","DOI":"10.7326\/0003-4819-104-1-74"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54: 2665-2673, 2006.","DOI":"10.1002\/art.21972"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of alkaptonuria. N Engl J Med 347: 2111-2121, 2002.","DOI":"10.1056\/NEJMoa021736"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tanios M, Brickman B, Norris J, et al. Spondyloarthropathies that mimic ankylosing spondylitis: a narrative review. Clin Med Insights Arthritis Musculoskelet Disord 16: 11795441231186822, 2023.","DOI":"10.1177\/11795441231186822"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee HC, Tsai TF. Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis. J Am Acad Dermatol 64: 1006-1007, 2011.","DOI":"10.1016\/j.jaad.2009.12.020"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsuo H, Asahina A, Fukuda T, Umezawa Y, Nakagawa H. Relapsing polychondritis associated with psoriasis vulgaris successfully treated with adalimumab: a case report with published work review. J Dermatol 44: 826-829, 2017.","DOI":"10.1111\/1346-8138.13796"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zeng Y, Li M, Chen S, et al. Is <sup>18<\/sup>F-FDG PET\/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy? Arthritis Res Ther 21: 282, 2019.","DOI":"10.1186\/s13075-019-2083-8"},{"key":"16","unstructured":"16. Gossec L, Kerschbaumer A, Ferreira RJO, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis 83: 706-719, 2024."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Moulis G, Pugnet G, Costedoat-Chalumeau N, et al. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Ann Rheum Dis 77: 1172-1178, 2018.","DOI":"10.1136\/annrheumdis-2017-212705"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rovensk\u00fd J, Letkovsk\u00e1 A, Schumacher HR, Urb\u00e1nek T, Bos\u00e1k V. Coexistence of ochronosis and rheumatoid arthritis: a cause of delay in diagnosis and treatment. J Clin Rheumatol 6: 214-217, 2000.","DOI":"10.1097\/00124743-200008000-00009"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6575-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:50Z","timestamp":1785557630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6575-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":18,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6575-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"6575-25"}}